Trans American Aquaculture (GRPS) Change in Account Payables (2023 - 2024)
Trans American Aquaculture (GRPS) reported Change in Account Payables of $107616.0 for Q3 2024, down 54.55% on a YoY basis from $236784.0 in Q4 2023, and up 185.86% quarter-over-quarter from -$125341.0 in Q2 2024.
Trans American Aquaculture (GRPS) Change in Account Payables (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported Change in Account Payables for 2 years, with the latest figure at $107616.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 107,616.00 |
| Sep 30, 2024 | 107,616.00 |
| Jun 30, 2024 | -125,341.00 |
| Jun 30, 2024 | -125,341.00 |
| Mar 31, 2024 | 23,950.00 |
| Mar 31, 2024 | 23,950.00 |
| Sep 30, 2023 | 236,784.00 |
| Sep 30, 2023 | 236,784.00 |
| Jun 30, 2023 | 111,435.00 |
| Jun 30, 2023 | 111,435.00 |
| Mar 31, 2023 | -4,283.00 |
| Mar 31, 2023 | -4,283.00 |